Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/29632
Title: Timescales of developmental toxicity impacting on research and needs for intervention
Authors: Grandjean, Philippe
Abdennebi-Najar, Latifa
Barouki, Robert
Cranor, Carl F.
Etzel, Ruth A.
Gee, David
Heindel, Jerrold J.
Hougaard, Karin S.
Hunt, Patricia
NAWROT, Tim 
Prins, Gail S.
Ritz, Beate
Soffritti, Morando
Sunyer, Jordi
Weihe, Pal
Issue Date: 2019
Source: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 125(SI 3), p. 70-80
Abstract: Much progress has happened in understanding developmental vulnerability to preventable environmental hazards. Along with the improved insight, the perspective has widened, and developmental toxicity now involves latent effects that can result in delayed adverse effects in adults or at old age and additional effects that can be transgenerationally transferred to future generations. Although epidemiology and toxicology to an increasing degree are exploring the adverse effects from developmental exposures in human beings, the improved documentation has resulted in little progress in protection, and few environmental chemicals are currently regulated to protect against developmental toxicity, whether it be neurotoxicity, endocrine disruption or other adverse outcome. The desire to obtain a high degree of certainty and verification of the evidence used for decision‐making must be weighed against the costs and necessary duration of research, as well as the long‐term costs to human health because of delayed protection of vulnerable early‐life stages of human development and, possibly, future generations. Although two‐generation toxicology tests may be useful for initial test purposes, other rapidly emerging tools need to be seriously considered from computational chemistry and metabolomics to CLARITY‐BPA‐type designs, big data and population record linkage approaches that will allow efficient generation of new insight; epigenetic mechanisms may necessitate a set of additional regulatory tests to reveal such effects. As reflected by the Prenatal Programming and Toxicity (PPTOX) VI conference, the current scientific understanding and the timescales involved require an intensified approach to protect against preventable adverse health effects that can harm the next generation and generations to come. While further research is needed, the main emphasis should be on research translation and timely public health intervention to avoid serious, irreversible and perhaps transgenerational harm.
Document URI: http://hdl.handle.net/1942/29632
ISSN: 1742-7835
e-ISSN: 1742-7843
DOI: 10.1111/bcpt.13162
ISI #: 000483744800007
Rights: 2018 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society)
Category: A1
Type: Journal Contribution
Validations: ecoom 2020
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
Grandjean_et_al-2019-Basic_&_Clinical_Pharmacology_&_Toxicology.pdf
  Restricted Access
Published version397.05 kBAdobe PDFView/Open    Request a copy
Show full item record

SCOPUSTM   
Citations

5
checked on Sep 3, 2020

WEB OF SCIENCETM
Citations

18
checked on Jul 10, 2024

Page view(s)

120
checked on Sep 7, 2022

Download(s)

90
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.